“…PD-1-based immunotherapy for the treatment of chronic infection was first shown in the chronic LCMV Cl-13 model (Barber et al, 2006), and was then shown to also be effective in the SIV model in macaques (Velu et al, 2009). Many studies on immune regulation have utilized the LCMV system (Bhattacharyya et al, 2017b;Bhattacharyya & Penaloza-MacMaster, 2017, 2018Im et al, 2016;Kamphorst et al, 2017;Penaloza-MacMaster et al, 2011;Penaloza-MacMaster, Kamphorst et al, 2014;Penaloza-MacMaster, Masopust, & Ahmed, 2009;Penaloza-MacMaster, Provine, Blass, & Barouch, 2015;Penaloza-MacMaster, Teigler et al, 2014;Vezys et al, 2011;Wang et al, 2019;West et al, 2013;West et al, 2011).…”